The ONCASPAR IV brand, founded in 2008 (United States), from 3 sister brands and 2214 competing brands. ONCASPAR IV is owned by Enzon Pharmaceuticals, listed on the stock exchange of Etats-Unis ONCASPAR IV is part of the Biotechnology activity sector.

ONCASPAR IV is a brand of Enzon Pharmaceuticals (ENZN) Share price

International deposit : 2008 Business sector Biotechnology

Share price and profitability of the share Enzon Pharmaceuticals (ONCASPAR IV)

Buy Enzon Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 0.08

Portfolio valuation
Enzon Pharmaceuticals (ONCASPAR IV) over 5 years* USD 0.03

Stock market history Enzon Pharmaceuticals (ONCASPAR IV)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Enzon Pharmaceuticals

Enzon Pharmaceuticals
Enzon Pharmaceuticals
See more brands of Enzon Pharmaceuticals

Rival brands
ONCASPAR IV

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS